Rachel Ochiel
Lead Research Nurse
Rachel has led the Rheumatology clinical trials unit at the Royal Free Hospital since 2006 where she has overall responsibility for all research work conducted in the department. Her role allows her to ensure that patients continue to receive high quality care while they participate in trials.
Lynda Bailey
Lead Rheumatology Nurse
Lynda leads a team of Rheumatology nurses including Clinical Nurse Specialists and the nursing workforce within the Rheumatology day case unit and outpatient setting. Her interests lie in RA Targeted Therapies with a passion for patient experience, a core component of the Assist RA programme.
Katy Pieris
Affiliate patient
Katy is a RA patient and affiliate member of our ASSIST RA steering committee. She volunteers for NRAS and has had an active role in supporting fellow patients during the pandemic this year. Listen to her story in our first ‘Joint discussions in RA’ podcast: Discussions with a patient
Barbara Douglas
Clinical Nurse Manager
With more than 27 years rheumatology experience, Barbara's role as a Clinical Nurse Manager and Advanced Nurse Practitioner allows her to support strategic planning of rheumatology from a nursing perspective to equip nurses with the necessary skills and confidence to work with the MDT to ensure that patients are always at the heart of the decision-making process.
Ruth Slack
Senior Rheumatology nurse
Ruth leads the rheumatology nursing team at West Suffolk Hospital. During her 25+ years of Rheumatology nursing, Ruth has chaired nurse educational meetings, spoken at national and international rheumatology events and chaired the Royal College of Nursing (RCN) Rheumatology Forum from 2013-2015
Sandra Robinson
Senior Nurse Researcher
Assist RA chair, Sandra, is passionate about the programme because it provides nurses with the opportunity to come together, share learnings and best practice and acquire the necessary skills and confidence to support gold-standard management of rheumatology patients
UK-RA-NA-202202-00009 | Date of preparation March 2023
Adverse events should be reported.
For Great Britain, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For Northern Ireland, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For the Republic of Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971.
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 00800 7878 1345.
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
© Copyright 2021 Galapagos NV
This link will take you away from the Galapagos website and you will be re-directed to a non-Galapagos website. Galapagos does not accept liability for sites controlled by third-parties.
*By choosing the "Healthcare Professional" option, you affirm your status as a healthcare professional in the UK and Ireland and acknowledge that you will receive promotional information pertaining to prescription-only medicines.